CN104042565A - 吗啡调配物、包含所述吗啡调配物的试剂盒和其用途 - Google Patents

吗啡调配物、包含所述吗啡调配物的试剂盒和其用途 Download PDF

Info

Publication number
CN104042565A
CN104042565A CN201410097764.7A CN201410097764A CN104042565A CN 104042565 A CN104042565 A CN 104042565A CN 201410097764 A CN201410097764 A CN 201410097764A CN 104042565 A CN104042565 A CN 104042565A
Authority
CN
China
Prior art keywords
formulation
morphine
buffer
months
dihydrate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201410097764.7A
Other languages
English (en)
Chinese (zh)
Inventor
阿莱纳·屈内
迪迪埃·瓦罗
波利娜·罗曼
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Fresenius Kabi Deutschland GmbH
Original Assignee
Becton Dickinson France SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Becton Dickinson France SA filed Critical Becton Dickinson France SA
Priority to CN201811072429.6A priority Critical patent/CN109125254A/zh
Publication of CN104042565A publication Critical patent/CN104042565A/zh
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Emergency Medicine (AREA)
  • Dermatology (AREA)
  • Inorganic Chemistry (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)
CN201410097764.7A 2013-03-14 2014-03-14 吗啡调配物、包含所述吗啡调配物的试剂盒和其用途 Pending CN104042565A (zh)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201811072429.6A CN109125254A (zh) 2013-03-14 2014-03-14 吗啡调配物、包含所述吗啡调配物的试剂盒和其用途

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201361785218P 2013-03-14 2013-03-14
US61/785,218 2013-03-14

Related Child Applications (1)

Application Number Title Priority Date Filing Date
CN201811072429.6A Division CN109125254A (zh) 2013-03-14 2014-03-14 吗啡调配物、包含所述吗啡调配物的试剂盒和其用途

Publications (1)

Publication Number Publication Date
CN104042565A true CN104042565A (zh) 2014-09-17

Family

ID=50288050

Family Applications (2)

Application Number Title Priority Date Filing Date
CN201811072429.6A Pending CN109125254A (zh) 2013-03-14 2014-03-14 吗啡调配物、包含所述吗啡调配物的试剂盒和其用途
CN201410097764.7A Pending CN104042565A (zh) 2013-03-14 2014-03-14 吗啡调配物、包含所述吗啡调配物的试剂盒和其用途

Family Applications Before (1)

Application Number Title Priority Date Filing Date
CN201811072429.6A Pending CN109125254A (zh) 2013-03-14 2014-03-14 吗啡调配物、包含所述吗啡调配物的试剂盒和其用途

Country Status (8)

Country Link
US (7) US9072781B2 (enExample)
EP (2) EP3143988A1 (enExample)
JP (1) JP6215970B2 (enExample)
CN (2) CN109125254A (enExample)
AU (1) AU2014230834B9 (enExample)
BR (1) BR112015021586B1 (enExample)
CA (1) CA2902343C (enExample)
WO (1) WO2014140095A1 (enExample)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2695158T3 (es) 2013-03-14 2019-01-02 Fresenius Kabi Deutschland Gmbh Sistema de envasado para fármacos sensibles al oxígeno
US9072781B2 (en) 2013-03-14 2015-07-07 Becton, Dickinson France S.A.S. Morphine formulations
US12144861B2 (en) * 2014-12-03 2024-11-19 Csl Behring Ag Pharmaceutical product with increased stability comprising immunoglobulins
US20170189352A1 (en) 2015-03-13 2017-07-06 Par Pharmaceutical, Inc. Epinephrine formulations
US9119876B1 (en) 2015-03-13 2015-09-01 Par Pharmaceutical, Inc. Epinephrine formulations
US11369700B2 (en) 2015-05-25 2022-06-28 IGL Pharma Inc. DOTMP kit formulations for radioisotopes
WO2016191413A1 (en) * 2015-05-25 2016-12-01 Iso Therapeutics Group, Llc Dotmp kit formulations for radioisotopes
EP3290025B1 (en) 2016-09-02 2020-02-12 Sun Pharmaceutical Industries Ltd Stable infusion dosage form of morphine
EP3515412B1 (en) * 2016-09-23 2025-04-23 Grünenthal GmbH Stable formulation for parenteral administration of tapentadol
WO2019183416A1 (en) 2018-03-23 2019-09-26 Nevakar Inc. Epinephrine compositions and containers
WO2021022045A1 (en) 2019-07-31 2021-02-04 Ecolab Usa Inc. Personal protective equipment free delimer compositions
US11806320B2 (en) * 2020-02-19 2023-11-07 Endo Ventures Limited Isoproterenol compositions and methods
WO2022131117A1 (ja) * 2020-12-18 2022-06-23 富士フイルム富山化学株式会社 医薬組成物

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1767831A (zh) * 2003-04-08 2006-05-03 普罗热尼奇制药公司 包含甲基纳曲酮的药物配方
WO2007022609A1 (en) * 2005-08-23 2007-03-01 Cristália Produtos Químicos Farmacêuticos Ltda. Pharmaceutical composition of morphine in ready-to-use injectable solution form and single dosage form of morphine for epidural or intrathecal administration

Family Cites Families (80)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1048712A (en) 1912-02-23 1912-12-31 John Uri Lloyd Process of extracting, purifying, or excluding alkaloids and alkaloidal salts.
US2715627A (en) 1952-05-26 1955-08-16 Charles L Mehltretter Solvent extraction of opium alkaloids
US4071620A (en) 1977-01-10 1978-01-31 American Home Products Corporation Stabilization of oxygen sensitive dose forms
JPS56125876U (enExample) 1980-02-23 1981-09-25
US4367738A (en) 1981-10-28 1983-01-11 Janssen Pharmaceutica Inc. Pre-filled syringe for abusable drugs
DE3376194D1 (en) 1982-10-08 1988-05-11 Terumo Corp Evacuated blood collecting device
US4998400A (en) 1986-03-22 1991-03-12 Material Engineering Technology Laboratory, Incorporated Medical fluid-filled plastic container and methods of making same
JPS6311160A (ja) 1986-07-02 1988-01-18 株式会社新素材総合研究所 薬液容器収納体及びその製造方法
US5723147A (en) 1987-02-23 1998-03-03 Depotech Corporation Multivesicular liposomes having a biologically active substance encapsulated therein in the presence of a hydrochloride
US5807572A (en) 1988-02-18 1998-09-15 Depotech Corporation Multivesicular liposomes having a biologically active substance encapsulated therein in the presence of a hydrochloride
US5030216A (en) 1989-12-15 1991-07-09 Alza Corporation Osmotically driven syringe
JP3630436B2 (ja) 1991-11-13 2005-03-16 株式会社創研 米からの活性酸素消去剤
GB9200219D0 (en) 1992-01-07 1992-02-26 Medimech Int Ltd Automatic injectors
AU5898794A (en) 1992-12-14 1994-07-04 Mallinckrodt Medical, Inc. Methods of producing prefilled delivery devices without exterior or interior contamination
CA2120197A1 (en) * 1993-04-02 1994-10-03 Kenji Endo Stable aqueous dispersions containing liposomes
US5414049A (en) 1993-06-01 1995-05-09 Howmedica Inc. Non-oxidizing polymeric medical implant
SE9401986D0 (sv) 1994-06-08 1994-06-08 Pharmacia Ab New process for sterilization and articles sterilized thereby
US6196998B1 (en) 1994-12-12 2001-03-06 Becton Dickinson And Company Syringe and tip cap assembly
US5624402A (en) 1994-12-12 1997-04-29 Becton, Dickinson And Company Syringe tip cap
US5931809A (en) 1995-07-14 1999-08-03 Depotech Corporation Epidural administration of therapeutic compounds with sustained rate of release
US6054584A (en) 1996-11-19 2000-04-25 The Board Of Regents Of The University And Community College System Of Neveda Process for extracting and purifying morphine from opium
SE9601348D0 (sv) 1996-04-10 1996-04-10 Pharmacia Ab Improved containers for parenteral fluids
EP0909555B1 (en) 1996-06-17 2004-05-26 Otsuka Pharmaceutical Factory, Inc. Package for container of liquid medicine containing bicarbonate
EP0954327A1 (en) 1996-06-28 1999-11-10 Oxigene, Inc. Useful formulations of acid addition salt drugs
US5997899A (en) 1996-10-01 1999-12-07 Skyepharma Inc. Method for producing liposomes with increased percent of compound encapsulated
JPH10182687A (ja) 1996-10-21 1998-07-07 Bayer Yakuhin Kk アカルボースの貯蔵安定化法
ATE269722T1 (de) 1996-12-16 2004-07-15 Univ Louisiana State Kanüle mit stumpfen ende und zugangszapfen
US5891467A (en) 1997-01-31 1999-04-06 Depotech Corporation Method for utilizing neutral lipids to modify in vivo release from multivesicular liposomes
WO1998045191A1 (en) 1997-04-10 1998-10-15 Johns Hopkins University Gaz syringe and package therefor
JPH1147274A (ja) 1997-06-03 1999-02-23 Takeda Chem Ind Ltd ２室型注射器及び２室型注射器用接続具
WO1999022691A1 (en) 1997-10-31 1999-05-14 Abbott Laboratories System for storing oxygen sensitive compositions
US6200627B1 (en) 1998-03-17 2001-03-13 Becton, Dickinson And Company Low silicone glass prefillable syringe
US6361524B1 (en) 1998-04-14 2002-03-26 Becton, Dickinson And Company Syringe assembly
US6217550B1 (en) 1998-07-29 2001-04-17 Becton, Dickinson And Company Single-use syringe
US6333087B1 (en) 1998-08-27 2001-12-25 Chevron Chemical Company Llc Oxygen scavenging packaging
AU6046900A (en) * 1999-06-16 2001-01-02 Nastech Pharmaceutical Company, Inc Method for increasing the solubility of morphine and pharmaceutical compositionsprepared therefrom
US7137968B1 (en) 2000-03-13 2006-11-21 Nucryst Pharmaceuticals Corp. Transcutaneous medical device dressings and method of use
US6875400B2 (en) 2000-12-22 2005-04-05 Cryovac, Inc. Method of sterilizing and initiating a scavenging reaction in an article
JP2002253641A (ja) 2001-03-01 2002-09-10 Terumo Corp プレフィルドシリンジ用注射器包装体
EP1241110A1 (en) 2001-03-16 2002-09-18 Pfizer Products Inc. Dispensing unit for oxygen-sensitive drugs
EP1243524A3 (en) 2001-03-16 2004-04-07 Pfizer Products Inc. Pharmaceutical kit for oxygen-sensitive drugs
JP2003052819A (ja) 2001-08-10 2003-02-25 Seikagaku Kogyo Co Ltd 薬剤充填注射器包装物およびその滅菌または殺菌方法
CA2465436A1 (en) 2001-11-02 2003-05-15 Meridian Medical Technologies, Inc. A medicament container, a medicament dispensing kit for administering medication and a method for packaging the same
US6870273B2 (en) 2002-04-29 2005-03-22 Pmc-Sierra, Inc. High speed I/O pad and pad/cell interconnection for flip chips
JP2004057321A (ja) 2002-07-26 2004-02-26 Shionogi & Co Ltd 収着酸素が除去されたプラスチック容器
KR20050051685A (ko) 2002-10-08 2005-06-01 가부시키가이샤 오츠까 세이야꾸 고죠 서스펜더 형성 구조 및 이 구조를 갖는 약제 용기
US20040102476A1 (en) 2002-11-25 2004-05-27 Chan Tai Wah High concentration formulations of opioids and opioid derivatives
EP1581287A1 (en) 2002-12-23 2005-10-05 Medtronic, Inc. Multiple infusion section catheters, systems, and methods
US7762044B2 (en) 2003-01-27 2010-07-27 Medtronic Vascular, Inc. Packaging for stent delivery systems
JP2004229750A (ja) 2003-01-28 2004-08-19 Nipro Corp プレフィルドシリンジ及びそのバレルの製造方法
WO2004084767A1 (en) 2003-03-25 2004-10-07 Medtronic Vascular Connaught Packaging for stents and stent delivery systems_________
US20040243214A1 (en) 2003-04-23 2004-12-02 Medtronic Vascular, Inc. Coated stent with protective packaging and method of using same
CA2526902C (en) 2003-04-23 2013-03-12 Otsuka Pharmaceutical Factory, Inc. Drug solution filling plastic ampoule and production method therefor
FR2855413B1 (fr) 2003-05-26 2005-12-30 Becton Dickinson France Seringue pre-remplie avec coiffe anti effraction
RS20060081A (sr) 2003-08-05 2008-06-05 Zentiva A.S., Postupci za stabilizaciju atorvastatina
US20050085785A1 (en) 2003-10-17 2005-04-21 Sherwin Shang High impact strength film and non-pvc containing container and pouch and overpouch
US20050228336A1 (en) 2004-04-07 2005-10-13 Preston Keusch Electrically assisted lidocaine and epinephrine delivery device having extended shelf-stability
JP4759232B2 (ja) 2004-07-02 2011-08-31 テルモ株式会社 包装されたプレフィルドシリンジの製造方法
JP2008506439A (ja) 2004-07-16 2008-03-06 ファイザー・プロダクツ・インク 低水分及び低酸素レベルを同時に維持するための医薬品包装容器
US7938580B2 (en) 2004-12-08 2011-05-10 Perfecseal, Inc. Sterilizable package with a high barrier to oxygen
JP4939405B2 (ja) 2005-04-28 2012-05-23 株式会社大塚製薬工場 薬液容器収容体およびその製造方法
JP4941303B2 (ja) 2005-08-22 2012-05-30 ニプロ株式会社 プレフィルドシリンジ
TWI489984B (zh) 2006-08-04 2015-07-01 Wyeth Corp 用於非經腸道傳輸化合物之配方及其用途
JP2008067989A (ja) 2006-09-15 2008-03-27 Terumo Corp プレフィルドシリンジ用収納容器および包装されたプレフィルドシリンジ
GB0619060D0 (en) 2006-09-27 2006-11-08 Glaxosmithkline Biolog Sa Novel process
CN101563057B (zh) 2006-10-27 2015-04-15 株式会社大塚制药工厂 溶解氧减少的液体制剂的制备方法、以及溶解氧含量减少的药液收容体
JP5411422B2 (ja) 2007-01-31 2014-02-12 関西電力株式会社 バイポーラ型半導体装置、その製造方法およびツェナー電圧の制御方法
US20080308444A1 (en) 2007-06-13 2008-12-18 Baxter International Inc. Packaging system and method of alerting a practitioner
US8002737B2 (en) 2007-10-04 2011-08-23 Hyprotek, Inc. Mixing/administration syringe devices, protective packaging and methods of protecting syringe handlers
JP5438896B2 (ja) 2007-12-27 2014-03-12 大日本印刷株式会社 プレフィルドシリンジ用の包装袋
US8623401B2 (en) * 2008-03-27 2014-01-07 Fenwafe Inc. Wafer formulation
FR2931681B1 (fr) 2008-05-30 2011-11-25 Becton Dickinson France Seringue a embout universel
US9095324B2 (en) 2008-06-20 2015-08-04 Boston Scientific Scimed, Inc. Package assembly
JP5587597B2 (ja) 2008-12-19 2014-09-10 藤森工業株式会社 包装体
JP5332958B2 (ja) 2009-06-29 2013-11-06 大日本印刷株式会社 プレフィルドシリンジ包装体及びプレフィルドシリンジ用パック
GB2471726B (en) 2009-07-10 2013-09-11 Oval Medical Technologies Ltd A pre-filled syringe including an oxygen absorber
PL2997965T3 (pl) 2009-07-22 2019-06-28 Grünenthal GmbH Odporna na manipulacje postać dawkowania opioidów wrażliwych na utlenianie
US9333288B2 (en) 2011-09-30 2016-05-10 Becton Dickinson France, S.A.S. Attachable plunger rod and associated packaging
US9072781B2 (en) 2013-03-14 2015-07-07 Becton, Dickinson France S.A.S. Morphine formulations
ES2695158T3 (es) 2013-03-14 2019-01-02 Fresenius Kabi Deutschland Gmbh Sistema de envasado para fármacos sensibles al oxígeno

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1767831A (zh) * 2003-04-08 2006-05-03 普罗热尼奇制药公司 包含甲基纳曲酮的药物配方
WO2007022609A1 (en) * 2005-08-23 2007-03-01 Cristália Produtos Químicos Farmacêuticos Ltda. Pharmaceutical composition of morphine in ready-to-use injectable solution form and single dosage form of morphine for epidural or intrathecal administration

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
注射剂的溶剂与附加剂;潘卫三等;《工业药剂学》;20100630;第215页 *
潘卫三等: "《工业药剂学》", 30 June 2010 *

Also Published As

Publication number Publication date
US20250228846A1 (en) 2025-07-17
JP2016512210A (ja) 2016-04-25
CA2902343C (en) 2022-08-02
US20190167665A1 (en) 2019-06-06
US9192608B2 (en) 2015-11-24
CN109125254A (zh) 2019-01-04
AU2014230834B2 (en) 2017-08-03
US20230414604A1 (en) 2023-12-28
US20150246036A1 (en) 2015-09-03
EP2968132B1 (en) 2017-09-13
EP3143988A1 (en) 2017-03-22
EP2968132A1 (en) 2016-01-20
US20160175297A1 (en) 2016-06-23
US20200345720A1 (en) 2020-11-05
US20140275144A1 (en) 2014-09-18
BR112015021586B1 (pt) 2023-01-31
BR112015021586A2 (pt) 2017-07-18
US10213424B2 (en) 2019-02-26
US9072781B2 (en) 2015-07-07
CA2902343A1 (en) 2014-09-18
WO2014140095A1 (en) 2014-09-18
AU2014230834A1 (en) 2015-09-10
JP6215970B2 (ja) 2017-10-18
AU2014230834B9 (en) 2017-08-31

Similar Documents

Publication Publication Date Title
US20250228846A1 (en) Morphine formulations
ES2655863T3 (es) Formulaciones para administración parenteral de compuestos y sus usos
MX2009002115A (es) Formulaciones de un compuesto en forma de polvo seco y usos de estas.
US20200268606A1 (en) Infusion bag of midazolam for intravenous use
AU2004280240B2 (en) Methylphenidate solution and associated methods of administration and production
WO2022072995A1 (en) Oral liquid compositions including chlorpromazine
EP2289489B1 (en) Compositions comprising cyclohexylamines and aminoadamantanes
HK1233500A1 (en) Injectable morphine formulations
CN113453663A (zh) 稳定的可注射肾上腺素水溶液
US20250195412A1 (en) Pharmaceutical formulations of r-ketamine
WO2014083071A1 (en) Injectable liquid formulation of the combination of tramadol and paracetamol
WO2025057112A1 (en) Bupivacaine liquid formulations
HK40055546B (zh) 稳定的可注射肾上腺素水溶液
HK1095737A1 (en) Medicinal composition in solution form
HK1238538A1 (en) Aqueous formulation comprising paracetamol and ibuprofen

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C41 Transfer of patent application or patent right or utility model
TA01 Transfer of patent application right

Effective date of registration: 20170113

Address after: German Homburg

Applicant after: Fresenius Kabi de GmbH

Address before: France Lepont de Clay

Applicant before: Bake Dun Dijinsen French company

RJ01 Rejection of invention patent application after publication

Application publication date: 20140917

RJ01 Rejection of invention patent application after publication